Results 231 to 240 of about 2,035,272 (261)
Some of the next articles are maybe not open access.

Pyroptosis in diabetes and diabetic nephropathy

Clinica Chimica Acta, 2022
Pyroptosis is identified as a pro-inflammatory programmed cell death, mediated by gasdermins (GSDMs) family of proteins accompanied by pro-inflammatory signals release. As essential players in innate immunity, inflammasomes are intracellular protein complexes which cleave gasdermin D (GSDMD), forming structurally stable pores in the cell membrane ...
Zhaohui, Cao   +6 more
openaire   +2 more sources

Pregnancy and diabetes

American Journal of Obstetrics and Gynecology, 1950
Abstract A review of 106 patients with 131 pregnancies complicated by diabetes has been presented. Past history of the multigravid patients indicated that the infants of the prediabetic mothers tended to be larger than average. The pregnancy of 75 per cent of the patients terminated after thirty-six weeks.
W P, GIVEN, R G, DOUGLAS, E, TOLSTOI
openaire   +2 more sources

Diabetic and non-diabetic neuropathies in patients with diabetes mellitus

Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova, 2018
Diabetic polyneuropathy is the most often complication of diabetes mellitus. However, patients with diabetes may have other neuropathies, which need to be recognized and treated. Chronic nnflammatory demyelinating polyneuropathy is the most common non-diabetic polyneuropathy in patients with diabetes.
L T, Akhmedzhanova   +2 more
openaire   +2 more sources

The cost of diabetes and diabetes care

Diabetes Research and Clinical Practice, 2001
The number of people with diabetes mellitus worldwide is estimated to be 221 million in 2010 compared to about 124 million in 1997. The dominant part of diabetic persons was in 1997 represented by Type 2 (97%). WHO expect the number of adults (20 years and older) with diabetes (i.e.
openaire   +2 more sources

Diabetic dyslipidaemia

European Journal of Clinical Investigation, 1994
Type 2 diabetic patients have an increased risk of cardiovascular disease and, although many factors contribute to this risk, it is likely that diabetic dyslipidaemia plays an important role. Dyslipidaemia in Type 2 diabetic patients is characterized by low levels of HDL cholesterol and high triglyceride levels.
openaire   +4 more sources

Diabetes

Postgraduate Medicine, 1980
openaire   +2 more sources

DIABETES

Medical Journal of Australia, 1968
openaire   +2 more sources

Targeting hepatic glucose metabolism in the treatment of type 2 diabetes

Nature Reviews Drug Discovery, 2016
Kfir Sharabi   +2 more
exaly  

New-Onset Diabetes in Covid-19

New England Journal of Medicine, 2020
Francesco Rubino   +2 more
exaly  

Managing diabetes with nanomedicine: challenges and opportunities

Nature Reviews Drug Discovery, 2014
Omid Veiseh   +2 more
exaly  

Home - About - Disclaimer - Privacy